Abstract
In order to analyze the state of the natural resistance system of bladder cancer patients in vivo, we measured natural killer (NK) activity and NK cell subsets of peripheral blood lymphocytes (PBL) from 46 patients with bladder cancer and 25 age- and sex-matched healthy volunteers. The mean NK activity in patients with lowstage bladder cancer was similar to that in the controls, while NK activity in patients with high-stage bladder cancer was significantly depressed. The mean proportions of Leu7+ cells in patients with both low-stage and highstage bladder cancer were significantly higher than that in the controls. The mean proportion of Leu11a+ cells in patients with low-stage bladder cancer was similar to that in the controls, while in patients with high-stage bladder cancer it was significantly higher. This study demonstrates the abnormal immunological state of bladder cancer patients; namely, abnormalities exist not only in NK activity but also in the proportions of circulating NK cell subsets.
Keywords: Cancer Patient, Cancer Research, Healthy Volunteer, Natural Killer, Natural Killer Cell
References
- 1.Abo T, Miller CA, Gartland GL, Balch CM. Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life. J Exp Med. 1983;157:273. doi: 10.1084/jem.157.1.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Balch CM, Tilden AB, Dougherty PA, Cloud GA, Abo T. Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients. Ann Surg. 1983;198:192. doi: 10.1097/00000658-198308000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Britten V, Rees RC, Clegg A, Smith GT, Potter CW, Fox M, Williams JL. Natural killer cell activity and response to phytohaemagglutinin compared with the histological diagnosis of patients with transitional cell carcinoma of the bladder. Br J Urol. 1982;54:261. doi: 10.1111/j.1464-410x.1982.tb06972.x. [DOI] [PubMed] [Google Scholar]
- 4.Catalona WJ, Tarpley JL, Chretien PB, Castle JR. Lymphocyte stimulation in urologic cancer patients. J Urol. 1974;112:373. doi: 10.1016/s0022-5347(17)59734-7. [DOI] [PubMed] [Google Scholar]
- 5.Herberman RB, Ortaldo JR. Natural killer cells: Their role in defenses against disease. Science. 1981;214:24. doi: 10.1126/science.7025208. [DOI] [PubMed] [Google Scholar]
- 6.Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF. Subpopulations of human natural killer cells defined by expression of the Leu7 (HNK-1) and Leu11 (NK-15) antigens. J Immunol. 1983;131:1789. [PubMed] [Google Scholar]
- 7.Lanier LL, Cwirla S, Federspiel N, Phillips JH. Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor chain genes. J Exp Med. 1986;163:209. doi: 10.1084/jem.163.1.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ma CP, Yu DS, Yeh MY, Chang SY, Han SH. Natural killer cell activity in patients with urologic cancer. Eur Urol. 1987;13:397. doi: 10.1159/000472833. [DOI] [PubMed] [Google Scholar]
- 9.Marshall VF. The relation to the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. J Urol. 1952;68:714. doi: 10.1016/S0022-5347(17)68271-5. [DOI] [PubMed] [Google Scholar]
- 10.Minato N, Bloom BR, Jones C, Holland J, Reid LM. Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med. 1979;149:1117. doi: 10.1084/jem.149.5.1117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Minato N, Reid L, Bloom BR. On the heterogeneity of murine natural killer cells. J Exp Med. 1981;154:750. doi: 10.1084/jem.154.3.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Morales A, Ottenhof PC. Clinical application of a whole blood assay for human natural killer (NK) cell activity. Cancer. 1983;52:667. doi: 10.1002/1097-0142(19830815)52:4<667::aid-cncr2820520417>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
- 13.Morita T, Yonese Y, Minato N. Evaluation of lymphocyte subpopulations in patients with bladder cancer: a study with monoclonal antibodies. Acta Urol Jpn. 1987;33:838. [PubMed] [Google Scholar]
- 14.Olsson CA, Rao CN, Menzoian JO, Byrd WE. Immunologic unreactivity in bladder cancer patients. J Urol. 1972;107:607. doi: 10.1016/s0022-5347(17)61090-5. [DOI] [PubMed] [Google Scholar]
- 15.Polli N, Matutes E, Robinson D, Catovsky D. Morphological heterogeneity of Leu7, Leu11 and OKM1 positive lymphocyte subsets: an ultrastructural study with the immunogold method. Clin Exp Immunol. 1987;68:331. [PMC free article] [PubMed] [Google Scholar]
- 16.Saksela E, Tarkkanen J, Carpen O, Virtanen J. Morphological and functional characteristics of human NK system. In: Serrou B, Rosenfeld C, Herberman RB, editors. Human cancer immunology: natural killer cells. New York: Elsevier Biomedical Press; 1982. pp. 81–82. [Google Scholar]
- 17.Schantz SP, Shillitoe EJ, Brown B, Campbell B. Natural killer cell activity and head and neck cancer: a clinical assessment. J Natl Cancer Inst. 1986;77:869. [PubMed] [Google Scholar]
- 18.Steinhauer EH, Doyle AT, Reed J, Kadish AS. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease. J Immunol. 1982;129:2255. [PubMed] [Google Scholar]
- 19.Takasugi M, Ramseyer A, Takasugi J. Decline of natural non-selective cell mediated cytotoxicity in patients with tumor progression. Cancer Res. 1977;37:413. [PubMed] [Google Scholar]
- 20.UICC: Union Internationale Contre le Cancer . TNM classification of malignant tumours. 3rd edn. Geneva: International Union Against Cancer; 1978. [Google Scholar]
- 21.Zagury D, Morgan DA, Fouchard M, Bernard J, Feldman M, Herberman RB. Heterogeneity of human natural killer cells. J Natl Cancer Inst. 1985;74:553. [PubMed] [Google Scholar]